IonQ revenue up 755% but the stock still fell - what is happening with quantum pure-plays

[DiamondDallas_X]

The disconnect between quantum computing commercial progress and stock performance has rarely been more stark. IonQ reported revenue growth of 755% year over year yet the stock fell 7% in early June alongside the broader quantum selloff triggered by the Broadcom earnings miss and SpaceX IPO liquidity rotation.

The sector-wide picture: IONQ down 7%, QBTS down 8%, RGTI and QUBT down 10% on June 5 alone. Rigetti trades at 592x price-to-sales and D-Wave at 606x. Quantinuum opened at $68 on debut, closed nearly flat at $62, then fell below its $60 IPO price on day two.

Yet the commercial fundamentals are genuinely improving. IonQ has $3.1 billion in cash, the strongest balance sheet in the pure-play sector. D-Wave bookings are up 2,000% to $33.4 million. IonQ crossed 99.99% two-qubit gate fidelity. The hardware is getting better. The valuations are getting punished

[Lucky Dean]

755% revenue growth and the stock falls. That is what happens when the price already reflected 1,500% revenue growth. The business is performing but the market bought a narrative not a business

[NightCrawler33]

D-Wave bookings up 2,000% is a genuinely extraordinary commercial signal buried under the noise of the sell-off. Future contracted revenue locking in at that rate means the customer adoption story is real even if the current reported revenue does not show it yet

[QueueDay]

The 592x price-to-sales ratio on Rigetti is the number that makes every other conversation about the sector redundant. You can have all the right technology and all the right commercial partnerships and still be catastrophically overvalued simultaneously

[TheGame92]

IonQ's $3.1 billion cash position is the detail that separates it from the rest of the pure-play sector. That is years of runway regardless of what happens to the stock price. The business can survive the valuation correction even if it is painful for shareholders

[Sorted Echo]

The SpaceX IPO draining liquidity from every high-beta name in the market hit quantum stocks particularly hard because the retail concentration in those names is very high. When retail sells to fund an IPO allocation the moves are exaggerated by the concentration